Clinical Trial Update: Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 trial examining teriflunomide’s effect on immune cell subsets in the blood of people with multiple sclerosis has completed, providing data on its immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (Aubagio) (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED